{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:10:57Z","timestamp":1788966657180,"version":"build-2803163510"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Recurrent pericarditis is uncommon in children with Down syndrome (DS) and may present diagnostic challenges. We report the case of a child with DS who developed massive pericardial effusion with minimal systemic inflammatory markers. Pericardial fluid analysis revealed markedly elevated interleukin-6 levels, suggesting localized cytokine-driven inflammation. Cardiac magnetic resonance (CMR) imaging revealed limited subepicardial enhancement with preserved ventricular function, findings consistent with pericarditis and secondary myocardial involvement rather than primary myocarditis. Combination therapy with ibuprofen and colchicine resulted in sustained remission without recurrence. This case highlights that significant pericardial inflammation may occur in patients with DS despite minimal systemic inflammation, and CMR imaging may assist in disease activity assessment and therapeutic decision-making.<\/jats:p>","DOI":"10.4103\/apc.apc_83_26","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:19:55Z","timestamp":1788949195000},"page":"576-580","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cytokine-driven recurrent pericarditis in Down syndrome: Role of pericardial fluid analysis and cardiac magnetic resonance imaging"],"prefix":"10.4103","volume":"19","author":[{"given":"Masaki","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Cardiology, Fukuoka Children\u2019s Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fukuoka Children\u2019s Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoshi","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Department of Hematology and Immunology, Fukuoka Children\u2019s Hospital, Fukuoka, Japan"},{"name":"Department of Pediatrics, Kyushu University Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Kuraoka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fukuoka Children\u2019s Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Sagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fukuoka Children\u2019s Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"R1-20260909","first-page":"1251","article-title":"Down syndrome in children: A primary immunodeficiency with immune dysregulation","volume":"11","author":"Szczawi\u0144ska-Pop\u0142onyk","year":"2024","journal-title":"Children (Basel)"},{"key":"R2-20260909","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC guidelines for the diagnosis and management of pericardial diseases: The task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"R3-20260909","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40265-025-02169-x","article-title":"Current drug treatment for acute and recurrent pericarditis","volume":"85","author":"Bonaventura","year":"2025","journal-title":"Drugs"},{"key":"R4-20260909","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11886-023-01839-0","article-title":"Pediatric pericarditis: Update","volume":"25","author":"Shahid","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"R5-20260909","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1055\/s-0038-1675337","article-title":"Fetal\/neonatal pericardial effusion in down\u2019s syndrome: case report and review of literature","volume":"8","author":"Pharande","year":"2018","journal-title":"AJP Rep"},{"key":"R6-20260909","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1620\/tjem.241.149","article-title":"Cytokine profiles in pericardial effusion in a down syndrome infant with transient abnormal myelopoiesis","volume":"241","author":"Shitara","year":"2017","journal-title":"Tohoku J Exp Med"},{"key":"R7-20260909","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41586-023-05736-y","article-title":"Autoimmunity in down\u2019s syndrome via cytokines, CD4 T cells and CD11c(+) B cells","volume":"615","author":"Malle","year":"2023","journal-title":"Nature"},{"key":"R8-20260909","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12016-024-08996-2","article-title":"Down syndrome and autoimmune disease","volume":"66","author":"Hom","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"R9-20260909","doi-asserted-by":"crossref","first-page":"24231","DOI":"10.1073\/pnas.1908129116","article-title":"Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity","volume":"116","author":"Araya","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-20260909","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1536\/ihj.20-282","article-title":"Responses to treatment according to the cytokine profiles of pericardial effusion in two children with idiopathic pericarditis","volume":"61","author":"Motonaga","year":"2020","journal-title":"Int Heart J"},{"key":"R11-20260909","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpeds.2022.11.034","article-title":"Pediatric recurrent pericarditis: Appropriateness of the standard of care and response to IL-1 blockade","volume":"256","author":"Caorsi","year":"2023","journal-title":"J Pediatr"},{"key":"R12-20260909","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejim.2025.03.011","article-title":"Recurrent pericarditis with normal C-reactive protein: Clinical and laboratory features, biomarkers and outcome in a non-inflammatory phenotype","volume":"135","author":"Mascolo","year":"2025","journal-title":"Eur J Intern Med"}],"container-title":["Annals of Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/apc.apc_83_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:18:09Z","timestamp":1788963489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/apc.apc_83_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/apc.apc_83_26","relation":{},"ISSN":["0974-2069","0974-5149"],"issn-type":[{"value":"0974-2069","type":"print"},{"value":"0974-5149","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-02-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}